Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap
Open Access
- 1 February 2021
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 26 (2) , 283-288
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020 (825881)
This publication has 18 references indexed in Scilit:
- PRIME time at the EMANature Reviews Drug Discovery, 2017
- Translating healthcare innovation from academia to industryAdvances in Mechanical Engineering, 2017
- The EMA Framework of Collaboration With Academic StakeholdersMolecular Therapy, 2016
- Development of cell therapy medicinal products by academic institutesDrug Discovery Today, 2016
- Putting translational science on to a global stageNature Reviews Drug Discovery, 2016
- The PCAST Report on Pharmaceutical Innovation: Implications for the FDAClinical Pharmacology & Therapeutics, 2013
- Raise standards for preclinical cancer researchNature, 2012
- From Research to Health Policy ImpactHealth Services Research, 2012
- Believe it or not: how much can we rely on published data on potential drug targets?Nature Reviews Drug Discovery, 2011
- What Are The Respective Roles Of The Public And Private Sectors In Pharmaceutical Innovation?Health Affairs, 2011